Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sandra A SpringerFrederick L Altice

Abstract

Responses to highly active antiretroviral therapy (HAART) in correctional settings and their sustained benefit in prisoners after release are currently not known. To examine the human immunodeficiency virus type 1 (HIV-1) RNA level (VL) and CD4 lymphocyte response to HAART during incarceration and upon reentry to the correctional system, we conducted a retrospective cohort study of longitudinally linked demographic, pharmacy, and laboratory data from the Connecticut prison system. During incarceration, the mean CD4 lymphocyte count increased by 74 lymphocytes/ mu L, and the mean VL decreased by 0.93 log10 copies/mL (P<.0001). Fifty-nine percent of the subjects achieved a VL of <400 copies/mL at the end of each incarceration period. For the 27% of subjects who were reincarcerated, the mean CD4 lymphocyte count decreased by 80 lymphocytes/ mu L, and the mean VL increased by 1.14 log10 (P<.0001). Although HAART use resulted in impressive VL and CD4 lymphocyte outcomes during the period of incarceration, recidivism to prison was high and was associated with a poor outcome. More effective community-release programs are needed for incarcerated patients with HIV disease.

Associated Clinical Trials

References

Dec 1, 1993·The American Journal of Medicine·P S DixonC C Carpenter
Aug 15, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·F MostashariF L Altice
Aug 26, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·F L AlticeE A Blanchette
Dec 22, 1999·AIDS·T P FlaniganA Spaulding
Jun 8, 2000·AIDS Patient Care and STDs·J BaillargeonK Dunn
Jul 13, 2000·JAMA : the Journal of the American Medical Association·S BabudieriG Starnini
Oct 6, 2000·Annals of Epidemiology·J BaillargeonC Leach
Oct 6, 2000·Annals of Epidemiology·C KozinetzA Cazazu
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J BaillargeonC T Leach
Mar 20, 2001·JAMA : the Journal of the American Medical Association·S L HaderS D Holmberg
Jun 12, 2001·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·O GrinsteadB Faigeles
Jun 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·J D RichT Flanigan
Sep 15, 2001·Journal of General Internal Medicine·B J TurnerS A Bozzette
Oct 2, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·F L AlticeG H Friedland
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer Adelson MittyTimothy Flanigan
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lynn M KirsteinUNKNOWN Women's Interagency HIV Study Collaborative Research Group
May 23, 2002·AIDS Patient Care and STDs·W Christopher MathewsTamara L Wall
Jul 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne SpauldingTimothy P Flanigan
Sep 14, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R StoneRichard T D'Aquila
Jan 4, 2003·Substance Use & Misuse·Ewald Witteveen, Erik J C van Ameijden
Jan 22, 2003·HIV Medicine·H CurtisUNKNOWN British HIV Association Clinical Audit Committee
Apr 18, 2003·AIDS·Steven G Deeks, Bernard Hirschel
Jun 20, 2003·Journal of Clinical and Experimental Neuropsychology·Roxanna FarinpourBarbara R Visscher
Jul 5, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gregory M LucasRichard D Moore
Jul 11, 2003·Lancet·A MocroftUNKNOWN EuroSIDA study group
Aug 22, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Frederick L AlticeGerald H Friedland
Aug 26, 2003·International Journal of STD & AIDS·Robin J MacGowanUNKNOWN Project START Study Group
Aug 29, 2003·The New England Journal of Medicine·Jody LawrenceUNKNOWN 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS

❮ Previous
Next ❯

Citations

Jan 15, 2009·JAMA : the Journal of the American Medical Association·Redonna K ChandlerNora D Volkow
Feb 27, 2009·JAMA : the Journal of the American Medical Association·Jacques BaillargeonDavid P Paar
Jan 29, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P Saiz de la HoyaUNKNOWN Prevalhep study group
Nov 9, 2011·AIDS and Behavior·Nadine E ChenFrederick L Altice
May 10, 2011·AIDS and Behavior·Sheryl L CatzJames M Sosman
Apr 18, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Elizabeth MarlowEnrique Menendez
Feb 3, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Shaili Gupta, Frederick L Altice
Feb 24, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Sandra Ann SpringerFrederick L Altice
Apr 16, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Amy J HarzkeMichael F Kelley
May 2, 2012·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Parya SaberiJacqueline P Tulsky
Dec 14, 2005·Current HIV/AIDS Reports·Sandra A Springer, Frederick L Altice
Sep 10, 2011·Current HIV/AIDS Reports·Josiah D RichUNKNOWN Centers for AIDS Research—Collaboration on HIV in Corrections (CFAR-CHIC) Working Group
Aug 24, 2007·The Lancet Infectious Diseases·Duncan Smith-Rohrberg MaruFrederick L Altice
Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amy Boutwell, Josiah D Rich
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sergio BabudieriGiovanni Rezza
Feb 16, 2006·AIDS Patient Care and STDs·Thomas LyonsJean Kiriazes
May 24, 2007·AIDS Patient Care and STDs·Faika ZanjaniDavid Oslin
Jun 23, 2010·AIDS Patient Care and STDs·Jacques BaillargeonDavid P Paar
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nickolas D ZallerCurt G Beckwith
Jun 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jaimie P MeyerFrederick L Altice
Apr 5, 2011·The Journal of Infectious Diseases·Timothy P Flanigan, Curt G Beckwith
Apr 28, 2006·Current Opinion in Psychiatry·David Wyatt Seal
Jan 10, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Duncan Smith-Rohrberg MaruFrederick L Altice
Nov 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Curt G BeckwithJosiah D Rich
Dec 3, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·M-J MilloyEvan Wood
Dec 12, 2012·Current Opinion in Infectious Diseases·Ryan P WestergaardTimothy P Flanigan
Jul 22, 2011·AIDS Research and Treatment·Jaimie P MeyerSandra A Springer
Oct 29, 2009·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Elizabeth MarlowCatherine A Chesla
Aug 7, 2008·Journal of Addictive Diseases·Barbara McGovern
Apr 4, 2012·PloS One·Natasha E C G Davies, Alan S Karstaedt
Jun 5, 2012·PloS One·Alex de VouxFrederick L Altice
Dec 25, 2009·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Anne C SpauldingGina M Wingood
Oct 19, 2010·HIV Therapy·Sarah E Wakeman, Josiah D Rich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Urban Health : Bulletin of the New York Academy of Medicine
Sandra A SpringerFrederick L Altice
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sandra A SpringerFrederick L Altice
Current HIV/AIDS Reports
Sandra A Springer, Frederick L Altice
© 2022 Meta ULC. All rights reserved